Buy now (impatient entry): Price ($69.17) is sitting just above key support (S1 ~$68.50) after a sharp drawdown; risk/reward favors a bounce setup rather than waiting for a “perfect” entry.
Street view is meaningfully bullish vs current price: Recent targets ($88–$117) imply large upside, suggesting the selloff may be overdone if earnings don’t disappoint.
Near-term catalyst risk: Earnings (QDEC 2025) on 2026-02-11 after hours can move the stock sharply; you’re buying into an event window.
Trend/Momentum: Bearish momentum still dominant — MACD histogram -1.228 and negatively expanding, consistent with a continuing downswing.
RSI (6): 22.075 indicates oversold conditions (bounce potential), even though momentum indicators still point down.
Moving averages: Converging MAs suggest the selloff may be entering a stabilization phase, but not a confirmed reversal yet.
Key levels: Current $69.17 is just above S1 $68.498 (near-term line in the sand). If that breaks, next support is S2 $64.941. Upside mean-reversion targets: Pivot $74.257, then R1 $80.016.
Pattern-based stats: Similar-pattern outcomes imply a positive skew: ~+1.67% next day, +3.72% next week, +8.71% next month (probabilistic, not guaranteed).
Options Data
Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Positioning (OI): Put/Call OI ratio 0.59 = call-leaning open interest (more constructive/bullish positioning).
Flow (Volume): Put/Call volume ratio 1.1 = slightly more puts traded today (near-term caution/hedging).
Volatility: 30D IV 34.45 vs HV 42.31; IV percentile 77.69 suggests options are relatively expensive vs recent history (market pricing elevated event risk into earnings).
Activity: Today’s option volume 225 is below 30-day average (today vs avg 37.5%), so sentiment signals from volume are less decisive.
Technical Summary
Sell
9
Buy
2
Positive Catalysts
increases odds of a reflex rally.
Neutral/Negative Catalysts
Momentum still bearish (MACD deteriorating); oversold can stay oversold if sellers persist.
Earnings catalyst risk (2026-02-11 A/H): Any miss or cautious commentary could break support and push toward S2 ~$64.94.
Deal integration risk: IPG acquisition synergy upside comes with execution/integration uncertainty; Morgan Stanley explicitly flagged opportunities and risks.
Macro tape pressure: Broader market weak (S&P 500 -1.25%), which can suppress near-term rebounds.
2025-12-10 (Citi): Maintained Buy, PT $103; flagged a 90-day upside catalyst watch into investor day expecting improved outlook/synergies.
2025-12-05 (UBS): Maintained Buy, PT $99 → $108 on accretion from the Interpublic deal.
Wall St. pros/cons summary:
Pros: Synergy + buyback potential from the IPG deal, multiple PT raises, catalyst-driven upside narrative.
Cons: Integration execution risk, recent margin/EPS pressure, and near-term event risk into earnings.
Other flows/checks:
Hedge funds: Neutral (no significant last-quarter trend).
Insiders: Neutral (no significant last-month trend).
Politicians/Congress: No recent congress trading data available (90 days).
People Also Watch
Wall Street analysts forecast OMC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OMC is 91.5 USD with a low forecast of 77 USD and a high forecast of 108 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast OMC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OMC is 91.5 USD with a low forecast of 77 USD and a high forecast of 108 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
2 Hold
1 Sell
Moderate Buy
Current: 69.120
Low
77
Averages
91.5
High
108
Current: 69.120
Low
77
Averages
91.5
High
108
JPMorgan
NULL -> Overweight
upgrade
$103 -> $117
AI Analysis
2026-01-23
Reason
JPMorgan
Price Target
$103 -> $117
AI Analysis
2026-01-23
upgrade
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on Omnicom to $117 from $103 and keeps an Overweight rating on the shares. The firm updated the company's model to reflect the IPG acquisition. It built in greater synergies and repurchases, partly offset by assumed agency sales and/or closures.
Morgan Stanley
Equal Weight
initiated
$88
2025-12-16
Reason
Morgan Stanley
Price Target
$88
2025-12-16
initiated
Equal Weight
Reason
Morgan Stanley resumed coverage of Omnicom with an Equal Weight rating and $88 price target. The firm says the company's deal integration brings both opportunities and risks.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for OMC
